Martha Stewart Moving Into A Big House?

1) Since this Martha Stewart stock caper gets better with each passing day, here's one of the key documents gathered so far by congressional investigators probing possible insider trading of ImClone stock. As you probably know, Stewart sold nearly 4000 shares of the biotech firm last December 27, the day before the company announced that the Food and Drug Administration had rejected ImClone's application for marketing approval for its anti-cancer drug Erbitux.On the day Stewart unloaded those shares, she tried to reach her pal Sam Waksal, then ImClone's CEO. But Martha had to leave a message, which was recorded by a secretary in Waksal's phone log, a page from which you'll find here. "Something," of course, was going on with ImClone, events that would not only trigger a precipitous decline in the firm's stock price, but which resulted in Waksal's recent indictment on insider-trading charges. Now prosecutors are focusing on not only what Martha knew, but when and how she knew it. Perhaps it's just one of those funny coincidences. Or maybe mercurial Martha's next household project will involve churning out somerather tasteful license plates. (1 page)

2) Speaking of license plates, click here for our latest hilarious sampling of supposedly objectionable tags.